Kenji Kunieda

A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)

Ken Kato, Taroh Satoh, Kei Muro et al. · Gastric Cancer · 2018 · 72 citations · Full text

Medicine, Oncology, Pharmacology +15

Antimicrobial stewardship without infectious disease physician for patients with candidemia: A before and after study

Minoru Murakami, Hirokazu Komatsu, Masahide Sugiyama et al. · Journal of General and Family Medicine · 2018 · 29 citations · Full text

Pharmacy, Infectious Diseases, Antimicrobial Stewardship +14

First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study

Akitaka Makiyama, Kenji Kunieda, Masaaki Noguchi et al. · Gastric Cancer · 2018 · 18 citations · Full text

Medicine, Geriatric Medicine, Oncology +8

Phase II study of S-1 plus oxaliplatin 130 mg/m2 in Japanese patients with advanced gastric cancer

Yosuke Kito, Nozomu Machida, S. Kawai et al. · International Journal of Clinical Oncology · 2018 · 12 citations

Medicine, Oncology, Pharmacokinetics +11